_id
6911bb27ccc777a4e85d61a9
Ticker
GENFF
Name
Genflow Biosciences plc
Exchange
OTCMKTS
Address
6 Heddon Street, London, United Kingdom, W1B 4BT
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://genflowbio.com
Description
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the fibroblasts in the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, which addresses mitochondrial dysfunction observed in sarcopenia for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was founded in 2020 and is headquartered in London, the United Kingdom.
Last Close
0.036
Volume
-
Current Price
0.0299
Change
0
Last Updated
2026-01-03T12:30:22.974Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
17767724
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.922
Sentiment Sources
1
Current Quarter
2023-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
493547942
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
1507437
Short Term Investments
-
Receivables
378037
Inventories
-
Total Current Assets
1908328
Property Plant Equipment
3991
Total Assets
1912319
Payables
194134
Short Term Debt
-
Long Term Debt
-
Total Liabilities
194134
Equity
1718185
Bs_currency_symbol
USD
Depreciation
207
Change In Working Capital
-
Cash From Operations
-422096
Capital Expenditures
2264
Cash From Investing
-2264
Cash From Financing
-
Net Change In Cash
-424394
Cf_currency_symbol
USD
PE
-
PB
5.090224788483196
ROE
-
ROA
-
FCF
-424360
Fcf Percent
-
Piotroski FScore
0
Health Score
55
Deep Value Investing Score
3
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
2.5
Garp Investing Score
1.5
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
2.5
Quality Investing Score
2
Value Investing Score
4
Quarters > 0 > quarter
2023-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
292506618
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
1507437
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
378037
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1908328
Quarters > 0 > balance Sheet > property Plant Equipment
3991
Quarters > 0 > balance Sheet > total Assets
1912319
Quarters > 0 > balance Sheet > payables
194134
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
194134
Quarters > 0 > balance Sheet > equity
1718185
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-310770
Quarters > 0 > cash Flow > depreciation
207
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-422096
Quarters > 0 > cash Flow > capital Expenditures
2264
Quarters > 0 > cash Flow > cash From Investing
-2264
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-424394
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
5.090224788483196
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-424360
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
55
Quarters > 1 > quarter
2023-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
378037
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1908328
Quarters > 1 > balance Sheet > property Plant Equipment
3991
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
194134
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
194134
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-310770
Quarters > 1 > cash Flow > depreciation
207
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-422096
Quarters > 1 > cash Flow > capital Expenditures
2264
Quarters > 1 > cash Flow > cash From Investing
-2264
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-424394
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-424360
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2022-12-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
292506618
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
2356225
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
2615110
Quarters > 2 > balance Sheet > property Plant Equipment
2351
Quarters > 2 > balance Sheet > total Assets
2617461
Quarters > 2 > balance Sheet > payables
83590
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
250988
Quarters > 2 > balance Sheet > equity
2366473
Quarters > 2 > balance Sheet > currency_symbol
GBP
Quarters > 2 > cash Flow > net Income
-280766
Quarters > 2 > cash Flow > depreciation
207
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-422096
Quarters > 2 > cash Flow > capital Expenditures
2264
Quarters > 2 > cash Flow > cash From Investing
-2264
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-424394
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
3.6957733632287373
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-424360
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
55
Quarters > 3 > quarter
2022-09-30
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
-
Quarters > 3 > balance Sheet > property Plant Equipment
-
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
-
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
-
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
-
Quarters > 3 > cash Flow > net Income
0
Quarters > 3 > cash Flow > depreciation
207
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-422096
Quarters > 3 > cash Flow > capital Expenditures
2264
Quarters > 3 > cash Flow > cash From Investing
-2264
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-424394
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-424360
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1587235
Annuals > 0 > income Statement > operating Income
-1587235
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-1587235
Annuals > 0 > income Statement > net Income
-1587235
Annuals > 0 > income Statement > eps
-0.004538761688519146
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
349706618
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
GBP
Annuals > 0 > balance Sheet > cash
278682
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
383841
Annuals > 0 > balance Sheet > property Plant Equipment
2067
Annuals > 0 > balance Sheet > total Assets
385908
Annuals > 0 > balance Sheet > payables
368897
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
788916
Annuals > 0 > balance Sheet > equity
-403008
Annuals > 0 > balance Sheet > currency_symbol
GBP
Annuals > 0 > cash Flow > net Income
-1587235
Annuals > 0 > cash Flow > depreciation
1179
Annuals > 0 > cash Flow > change In Working Capital
503783
Annuals > 0 > cash Flow > cash From Operations
-1082273
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
-425638
Annuals > 0 > cash Flow > currency_symbol
GBP
Annuals > 0 > ratios > PE
-0.004538761688519146
Annuals > 0 > ratios > PB
-31.23868074082896
Annuals > 0 > ratios > ROE
393.84702040654275
Annuals > 0 > ratios > ROA
-411.2988069695368
Annuals > 0 > ratios > FCF
-1082273
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
1860345
Annuals > 1 > income Statement > operating Income
-1860345
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-1860345
Annuals > 1 > income Statement > net Income
-1860345
Annuals > 1 > income Statement > eps
-0.006360009946851869
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
292506618
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
GBP
Annuals > 1 > balance Sheet > cash
683974
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
1068259
Annuals > 1 > balance Sheet > property Plant Equipment
3394
Annuals > 1 > balance Sheet > total Assets
1071653
Annuals > 1 > balance Sheet > payables
480917
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
571960
Annuals > 1 > balance Sheet > equity
499693
Annuals > 1 > balance Sheet > currency_symbol
GBP
Annuals > 1 > cash Flow > net Income
-1860345
Annuals > 1 > cash Flow > depreciation
1034
Annuals > 1 > cash Flow > change In Working Capital
198436
Annuals > 1 > cash Flow > cash From Operations
-1660875
Annuals > 1 > cash Flow > capital Expenditures
2439
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-1663314
Annuals > 1 > cash Flow > currency_symbol
GBP
Annuals > 1 > ratios > PE
-0.006360009946851869
Annuals > 1 > ratios > PB
21.07341557316192
Annuals > 1 > ratios > ROE
-372.2975907207025
Annuals > 1 > ratios > ROA
-173.59583745858035
Annuals > 1 > ratios > FCF
-1663314
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
1334943
Annuals > 2 > income Statement > operating Income
-1334943
Annuals > 2 > income Statement > interest Expense
382
Annuals > 2 > income Statement > pretax Income
-1335325
Annuals > 2 > income Statement > net Income
-1335325
Annuals > 2 > income Statement > eps
-0.004565110386664824
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
292506618
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-1334813
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
GBP
Annuals > 2 > balance Sheet > cash
2356225
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
2615110
Annuals > 2 > balance Sheet > property Plant Equipment
2351
Annuals > 2 > balance Sheet > total Assets
2617461
Annuals > 2 > balance Sheet > payables
83590
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
250988
Annuals > 2 > balance Sheet > equity
2366473
Annuals > 2 > balance Sheet > currency_symbol
GBP
Annuals > 2 > cash Flow > net Income
-1335325
Annuals > 2 > cash Flow > depreciation
129
Annuals > 2 > cash Flow > change In Working Capital
-176778
Annuals > 2 > cash Flow > cash From Operations
-1368854
Annuals > 2 > cash Flow > capital Expenditures
2480
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
2128183
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.004565110386664824
Annuals > 2 > ratios > PB
4.449760571111523
Annuals > 2 > ratios > ROE
-56.42680055931337
Annuals > 2 > ratios > ROA
-51.01604188180836
Annuals > 2 > ratios > FCF
-1371334
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
938096
Annuals > 3 > income Statement > operating Income
-938096
Annuals > 3 > income Statement > interest Expense
99
Annuals > 3 > income Statement > pretax Income
-988195
Annuals > 3 > income Statement > net Income
-988195
Annuals > 3 > income Statement > eps
-0.004040538591063688
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
244570118
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-988096
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
224004
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
19739
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
276551
Annuals > 3 > balance Sheet > property Plant Equipment
0
Annuals > 3 > balance Sheet > total Assets
276551
Annuals > 3 > balance Sheet > payables
37686
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
221427
Annuals > 3 > balance Sheet > equity
55124
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-1078031
Annuals > 3 > cash Flow > depreciation
-
Annuals > 3 > cash Flow > change In Working Capital
171759
Annuals > 3 > cash Flow > cash From Operations
-815320
Annuals > 3 > cash Flow > capital Expenditures
0
Annuals > 3 > cash Flow > cash From Investing
216548
Annuals > 3 > cash Flow > cash From Financing
854957
Annuals > 3 > cash Flow > net Change In Cash
244368
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-0.004040538591063688
Annuals > 3 > ratios > PB
159.72215818881068
Annuals > 3 > ratios > ROE
-1792.6765111385241
Annuals > 3 > ratios > ROA
-357.32830472498745
Annuals > 3 > ratios > FCF
-815320
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
8
Valuation > metrics > PB
5.090224788483196
Valuation > final Score
29.09775211516804
Valuation > verdict
69.7% Overvalued
Profitability > final Score
50
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.11298783309131438
Risk > final Score
80
Risk > verdict
Low
Liquidity > metrics > Current Ratio
9.829952507031226
Liquidity > metrics > Quick Ratio
9.829952507031226
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
43.04226636771263
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
80
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
50
Updated At
2026-01-20T21:53:38.756Z
Genflow Biosciences plc, together with its subsidiaries, engages in the research and development of gene therapy targeting the upstream biology of aging in the United Kingdom and Belgium. The company operates as a pre-clinical biotechnology company that focuses on developing biological interventions aimed at tackling the effects of aging, slowing, and halting the aging process, as well as reducing the incidence of age-related diseases. Its lead drug candidate is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-1003, a topical delivery of SIRT6 to the fibroblasts in the skin; GF-1004, a non-human pipeline anti-aging for veterinary use; GF-1005, which addresses mitochondrial dysfunction observed in sarcopenia for muscle health and combat sarcopenia; and GF-1006, an ophthalmology mRNA cent SIRT6 for the treatment of cornea pathologies and glaucoma. The company has collaborative research agreements with Revatis SA and EXO Biologics for therapy medicinal products. Genflow Biosciences plc was founded in 2020 and is headquartered in London, the United Kingdom.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AGenflow shares jump as biotech appoints new chairman Proactive financial news
Read more →Showing 2 of 10
(Last Updated 2023-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Genflow Biosciences plc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
No earnings data available.
(Last Updated 2023-06-30)
(Last Updated 2023-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2023-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.